Is Anyone Listening? Variation in PSA Screening among Providers for Men 75+ before and after United States Preventive Services Task Force Recommendations against It: A Retrospective Cohort Study

Background In 2008, the United States Preventive Services Task Force recommended against prostate specific antigen (PSA) testing for cancer screening in men age 75+. Purpose To assess PSA screening by primary care physicians (PCPs) before and after recommendations. Methods In 2013, this retrospective cohort study analyzed PCPs in Texas with 20+ male patients aged 75+ in both 2007 and 2010, with Parts A and B Medicare. The main outcome was percent of PCP’s male patients 75+ who received PSA testing ordered by the PCP in 2007 and 2010, with no recent symptoms suggestive of prostate cancer. Results In both 2007 and 2010, 1,083 PCPs cared for at least 20 men aged 75 or older. The rate of PSA screening ordered by PCPs was 33.2% in 2007 and 30.6% in 2010. In multilevel analyses controlling for patient characteristics, the variation in PSA screening attributable to the PCP (intraclass correlation coefficient) increased from 23% in 2007 to 26% in 2010, p<0.001. Men with PCPs older than age 60 had 9% lower odds (95% CI, 1–17%) in 2010 compared to 2007 of receiving a PSA test, vs. a 4% increase (95% CI, 4% decrease to 12% increase) in men with PCPs aged 50 or younger. Patients with Board Certified PCPs had a 12% lower odds (95% CI, 8% to 16%) from 2007 to 2010, vs. 2% increase (95% CI 11% decrease to 18% increase) in men with PCPs without board certification. Conclusions The USPSTF recommendation did not increase consensus among PCPs regarding PSA screening of older men.

[1]  T. Ahlering,et al.  The Melbourne Consensus Statement on the early detection of prostate cancer , 2014, BJU international.

[2]  J. Goodwin,et al.  Variation among primary care physicians in prostate-specific antigen screening of older men. , 2013, JAMA.

[3]  J. Goodwin,et al.  Predicting life expectancy for community-dwelling older adults from Medicare claims data. , 2013, American journal of epidemiology.

[4]  Kirsten L. Greene,et al.  Early detection of prostate cancer: AUA Guideline. , 2013, The Journal of urology.

[5]  J. Goodwin,et al.  Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials. , 2013, Journal of the National Cancer Institute.

[6]  Peter H. Schwartz,et al.  Older adults and forgoing cancer screening: "I think it would be strange". , 2013, JAMA internal medicine.

[7]  J. Goodwin,et al.  Refining Physician Quality Indicators for Screening Mammography in Older Women: Distinguishing Appropriate Use from Overuse , 2013, Journal of the American Geriatrics Society.

[8]  J. Goodwin,et al.  Primary care physicians and disparities in colorectal cancer screening in the elderly. , 2013, Health services research.

[9]  C. Gross,et al.  Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. , 2012, Archives of internal medicine.

[10]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[11]  Jim C Hu,et al.  2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. , 2012, JAMA.

[12]  C. Pollack,et al.  Primary care providers' response to the US Preventive Services Task Force draft recommendations on screening for prostate cancer. , 2012, Archives of internal medicine.

[13]  M. Katz.  Overuse of health care: where are the data? , 2012, Archives of internal medicine.

[14]  Jeffrey P. Cowan,et al.  PSA screening: determinants of primary-care physician practice patterns , 2011, Prostate Cancer and Prostatic Diseases.

[15]  Sei J. Lee,et al.  Quality indicators for older adults: preventing unintended harms. , 2011, JAMA.

[16]  James S. Goodwin,et al.  Tracking Medicine: A Researcher's Quest to Understand Health Care By John E. Wennberg , 2011 .

[17]  Ruth Etzioni,et al.  Influence of publication of US and European prostate cancer screening trials on PSA testing practices. , 2011, Journal of the National Cancer Institute.

[18]  A. Gerber,et al.  A national survey reveals public skepticism about research-based treatment guidelines. , 2010, Health affairs.

[19]  Julie Bynum,et al.  Regional variations in diagnostic practices. , 2010, The New England journal of medicine.

[20]  E. Fisher,et al.  Variation in Prostate‐Specific Antigen Screening in Men Aged 80 and Older in Fee‐for‐Service Medicare , 2010, Journal of the American Geriatrics Society.

[21]  Elizabeth A McGlynn,et al.  Physician cost profiling--reliability and risk of misclassification. , 2010, The New England journal of medicine.

[22]  Peter C Albertsen,et al.  Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. , 2009, Journal of the National Cancer Institute.

[23]  M. Fouad,et al.  Physician Knowledge, Perceptions of Barriers, and Patient Colorectal Cancer Screening Practices , 2009, American journal of medical quality : the official journal of the American College of Medical Quality.

[24]  P. Gimotty,et al.  Effect of Guidelines on Primary Care Physician Use of PSA Screening: Results from the Community Tracking Study Physician Survey , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[25]  Elliott S Fisher,et al.  Discretionary decision making by primary care physicians and the cost of U.S. Health care. , 2008, Health affairs.

[26]  A. Laupacis,et al.  Administrative data algorithms can describe ambulatory physician utilization. , 2007, Health services research.

[27]  L. Walter,et al.  PSA screening among elderly men with limited life expectancies. , 2006, JAMA.

[28]  H. Krumholz,et al.  Physician board certification and the care and outcomes of elderly patients with acute myocardial infarction , 2006, Journal of General Internal Medicine.

[29]  H. Quan,et al.  Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.

[30]  Floyd J Fowler,et al.  Enthusiasm for cancer screening in the United States. , 2004, JAMA.

[31]  R. Strawderman,et al.  Quantifying the Physician Contribution to Managed Care Pharmacy Expenses: A Random Effects Approach , 2002, Medical care.

[32]  Patrick C. Walsh,et al.  American Cancer Society Guidelines for the Early Detection of Cancer , 2002, CA: a cancer journal for clinicians.

[33]  J. Norcini,et al.  The Certification Status of Generalist Physicians and the Mortality of Their Patients after acute Myocardial Infarction , 2001, Academic medicine : journal of the Association of American Medical Colleges.

[34]  J. Brophy,et al.  Are patients suffering from stable angina receiving optimal medical treatment? , 2001, QJM : monthly journal of the Association of Physicians.

[35]  W. Manning,et al.  The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. , 1999, JAMA.

[36]  P. Spreeuwenberg,et al.  Patient satisfaction with the general practitioner: a two-level analysis. , 1998, Medical care.

[37]  A. Haines,et al.  Guidance on guidelines. , 1992, BMJ.

[38]  A D Mickalide,et al.  U.S. Preventive Services Task Force. , 1986, Pediatric clinics of North America.

[39]  J. Goodwin,et al.  The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[40]  Prostate-Specific Antigen ( PSA ) Best Practice Policy , 2013 .

[41]  P. Dahm,et al.  Screening for prostate cancer. , 2013, The Cochrane database of systematic reviews.

[42]  M. Nichol,et al.  Prostate cancer screening trends in a large, integrated health care system. , 2012, The Permanente journal.

[43]  Robert A Smith,et al.  American Cancer Society Guidelines for the Early Detection of Cancer, 2006 , 2006, CA: a cancer journal for clinicians.

[44]  T. Ricketts,et al.  The role of physician recommendation in women's mammography use: is it a 2-stage process? , 2000, Medical care.

[45]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.

[46]  T. Skolarus,et al.  Socioeconomic Factors , Urological Epidemiology and Practice Patterns Re : Prostate Cancer Screening in Men Ages 75 and Older Fell by 8 Percentage Points after Task Force Recommendation , 2022 .